Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec 23;31(4):e440-e445.
doi: 10.5301/jbm.5000212.

Involvement of myeloperoxidase gene polymorphism 463G>A in development of cervical squamous cell carcinoma

Andrzej Roszak  1   2 , Anna Lutkowska  3 , Margarita Lianeri  3 , Anna Sowińska  4 , Paweł P Jagodziński  3
Affiliations
Free article

Involvement of myeloperoxidase gene polymorphism 463G>A in development of cervical squamous cell carcinoma

Andrzej Roszak et al. Int J Biol Markers. .
Free article

Abstract

Background: The myeloperoxidase (MPO) -463G>A (rs2333227) polymorphism has been linked with increased susceptibility to the development of various malignancies. However, the data on the association of the MPO -463G>A transition with cervical cancer remain inconsistent.

Methods: Using high resolution melting analysis we genotyped this polymorphism in women with cervical squamous cell carcinoma (SCC) (n = 476) and controls (n = 493) from a Polish Caucasian population. Logistic regression analysis was used to adjust for the effect of confounders such as age, parity, oral contraceptive use, tobacco smoking, and menopausal status, and revealed that the MPO -463G>A single nucleotide polymorphism (SNP) was associated with an increased risk of SCC.

Results: The adjusted odds ratio (OR) for patients with the A/A genotype versus G/G genotype was 0.718 (95% CI 0.531-0.972, p = 0.0316). Stratified analyses between the MPO -463G>A polymorphism and SCC risks demonstrated a protective role of the MPO -463G>A SNP in patients with a positive history of parity and negative history of tobacco smoking. In patients with a positive history of parity, the age-adjusted OR for the A/A versus G/G genotype was 0.667 (95% CI 0.479-0.929, p = 0.0164). The age-adjusted OR for patients with a negative history of tobacco smoking for the A/A versus G/G genotype was 0.491 (95% CI 0.313-0.770, p = 0.0019).

Conclusions: Our study demonstrated that the MPO -463G>A SNP may protect from SCC in women from Polish Caucasian populations.

PubMed Disclaimer